A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer

Technology in Cancer Research and Treatment

Volumn 9, Issue 5, 2010, Pages 453-462

  Oermann, Eric K ^a   Slack, Rebecca S ^b   Hanscom, Heather N ^a   Lei, Sue ^a   Suy, Simeng ^a   Park, Hyeon U ^a   Kim, Joy S ^a   Sherer, Benjamin A ^a   Collins, Brian T ^a   Satinsky, Andrew N ^a   Harter, K William ^a   Batipps, Gerald P ^a   Constantinople, Nicholas L ^a   Dejter, Stephen W ^a   Maxted, William C ^a   Regan, James B ^a   Pahira, John J ^a   McGeagh, Kevin G ^a   Jha, Reena C ^a   Dawson, Nancy A ^a   Dritschilo, Anatoly ^a   Lynch, John H ^a   Collins, Sean P ^a   more..

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Acute toxicity; Common toxicity criteria (CTC); CyberKnife; EPIC; IMRT; Prostate cancer; Quality of life; SBRT

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ANTIANDROGEN THERAPY; ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CYBERKNIFE; DIARRHEA; DYSURIA; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMATURIA; HIGH RISK PATIENT; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NEPHROTOXICITY; PILOT STUDY; PROCTITIS; PROSTATE CANCER; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM HEMORRHAGE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; URINARY URGENCY; URINE INCONTINENCE; URINE RETENTION;

EID: 78049299080     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303461000900503     Document Type: Article

References (26)

1. Fuks, Z., Leibel, S. A., Wallner, K. E., Begg, C. B., Fair, W. R., Ander son, L. L., Hilaris, B. S., Whitmore, W. F. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. Int J Radiat Oncol Biol Phys 21, 537-547 (1991).
2. Dearnaley, D. P., Khoo, V. S., Norman, A. R., Meyer, L., Nahum, A., Tait, D., Yarnold, J., Horwich, A. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353, 267-272 (1999).
3. Beard, C. J., Kaplan, I. D., Coleman, C. N. The challenge for conformal therapy for prostate cancer. Int J Radiat Oncol Biol Phys 26, 705-707 (1993).
4. Zelefsky, M. J., Chan, H., Hunt, M., Yamada, Y., Shippy, A. M., Amols, H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 176, 1415-1419 (2006).
5. Kuban, D. A., Levy, L. B., Cheung, M. R., Lee, A. K., Choi, S., Frank, S., Pollack, A. Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease? Int J Radiat Oncol Biol Phys, In Press.
6. Stone, N. N., Potters, L., Davis, B. J., Ciezki, J. P., Zelefsky, M. J., Roach, M., Shinohara, K., Fearn, P. A., Kattan, M. W., Stock, R. G. Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 73, 341-346 (2009).
7. Martinez, A. A., Gustafson, G., Gonzalez, J., Armour, E., Mitchell, C., Edmundson, G., Spencer, W., Stromberg, J., Huang, R., Vicini, F. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 53, 316-327 (2002).
8. Fowler, J. F. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol 44, 265-276 (2005).
9. Phan, T. P., Syed, A. M., Puthawala, A., Sharma, A., Khan, F. High dose rate brachytherapy as a boost for the treatment of localized prostate cancer. J Urol 177, 123-127; discussion 127 (2007). (Pubitemid 44879443)
10. Demanes, D. J., Rodriguez, R. R., Schour, L., Brandt, D., Altieri, G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 61, 1306-1316 (2005).
11. Nuernberg, N., Eulau, S., Gustafson, G., Gribble, M., Kovacs, G. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 58, 1048-1055 (2004).
12. Hiratsuka, J., Jo, Y., Yoshida, K., Nagase, N., Fujisawa, M., Imajo, Y. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 59, 684-690 (2004).
13. Webb, S. Conformal intensity-modulated radiotherapy (IMRT) delivered by robotic linac - testing IMRT to the limit? Phys Med Biol 44, 1639-1654 (1999).
14. Hossain, S., Xia, P., Huang, K., Descovich, M., Chuang, C., Gottschalk, A. R., Roach, M., III, Ma, L. Dose Gradient Near Target-Normal Structure Interface for Nonisocentric CyberKnife and Isocentric Intensity-Modulated Body Radiotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys, In Press.
15. Fuller, D. B., Naitoh, J., Lee, C., Hardy, S., Jin, H. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 70, 1588-1597 (2008).
16. Xie, Y., Djajaputra, D., King, C. R., Hossain, S., Ma, L., Xing, L. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 72, 236-246 (2008).
17. King, C. R., Brooks. J. D., Gill, H., Pawlicki, T., Cotrutz, C., Presti, J. C., Jr. Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical Trial. Int J Radiat Oncol Biol Phys 73, 1043-1048 (2009).
18. Barry, M. J., Fowler, F. J., Jr., O'Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K., Cockett, A. T. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 148, 1549-1557; discussion 1564 (1992).
19. Wei, J.T., Dunn, R. L., Litwin, M. S., Sandler, H. M., Sanda, M. G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56, 899-905 (2000).
20. Rosen, R. C, Cappelleri, J. C., Gendrano, N, III. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 14, 226-244 (2002).
21. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A., Tomaszewski, J. E., Renshaw, A. A., Kaplan, I., Beard, C. J., Wein, A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. Jama 280, 969-974 (1998).
22. Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., Mahadevan, A., Klein, E., Kibel, A., Pisters, L. L., Kuban, D., Kaplan, I., Wood, D., Ciezki, J., Shah, N., Wei, J. T. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 358, 1250-1261 (2008).
23. Hurwitz, M. D., Halabi, S., Ou, S. S., McGinnis, L. S., Keuttel, M. R., Dibiase, S. J., Small, E. J. Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809. Int J Radiat Oncol Biol Phys 72, 814-819 (2008).
24. Valero, J., Cambeiro, M., Galan, C., Teijeira, M., Romero, P., Zudaire, J., Moreno, M., Ciervide, R., Aristu, J. J., Martinez-Monge R. Phase II Trial of Radiation Dose Escalation with Conformal External Beam Radiotherapy and High-Dose-Rate Brachytherapy Combined with Long-Term Androgen Suppression in Unfavorable Prostate Cancer: Feasibility Report. Int J Radiat Oncol Biol Phys 76, 386-392 (2009).
25. Martin, T., Roddiger, S., Kurek, R., Dannenberg, T., Eckart, O., Kolotas, C., Heyd, R., Rogge, B., Baltas, D., Tunn, U., Zamboglou, N. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiother Oncol 71, 35-41 (2004).
26. Sato, M., Mori, T., Shirai, S., Kishi, K., Inagaki, T., Hara, I. High-dose-rate brachytherapy of a single implant with two fractions combined with external beam radiotherapy for hormone-naive prostate cancer. Int J Radiat Oncol Biol Phys 72, 1002-1009 (2008).